Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: Generation of attenuated strains of the virus

Vaccine

Volumn 26, Issue 1, 2007, Pages 15-23

  Chiou, Shyan Song ^a,b   Chen, Wei June ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Japanese encephalitis virus; Live attenuated vaccine; Virus selection

Indexed keywords

GLUTAMIC ACID; GLYCOPROTEIN E1; GLYCOSAMINOGLYCAN POLYSULFATE; JAPANESE ENCEPHALITIS VACCINE; LYSINE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS CULTURE; VIRUS STRAIN;

ANIMALS; BRAIN; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; ENCEPHALITIS VIRUS, JAPANESE; HEPARIN; JAPANESE ENCEPHALITIS VACCINES; MICE; MICE, INBRED ICR; NEUROBLASTOMA; PHENOTYPE; VACCINES, ATTENUATED; VERO CELLS; VIRULENCE;

EID: 36749094116     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.047     Document Type: Article

References (42)

1. Hanna J.N., Ritchie S.A., Phillips D.A., Shield J., Bailey M.C., Mackenzie J.S., et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 165 (1996) 256-260
2. Mackenzie J.S., Johansen C.A., Ritchie S.A., van den Hurk A.F., and Hall R.A. Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia. Curr Top Microbiol Immunol 267 (2002) 49-73
3. Endy T.P., and Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 267 (2002) 11-48
4. Igarashi A. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control. Curr Top Microbiol Immunol 267 (2002) 139-152
5. Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, October 13-15, 1998. Vaccine 2000;18 (Suppl. 2):1-25.
6. Plesner A.M. Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin N Am 23 (2003) 665-697
7. Chambers T.J., Tsai T.F., Pervikov Y., and Monath T.P. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine 15 (1997) 1494-1502
8. Marfin A.A., and Gubler D.J. Japanese encephalitis: the need for a more effective vaccine. Lancet 366 (2005) 1335-1337
9. Sugawara K., Nishiyama K., Ishikawa Y., Abe M., Sonoda K., Komatsu K., et al. Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Biologicals 30 (2002) 303-314
10. Srivastava A.K., Putnak J.R., Lee S.H., Hong S.P., Moon S.B., Barvir D.A., et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 19 (2001) 4557-4565
11. Nitayaphan S., Grant J.A., Chang G.J., and Trent D.W. Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology 177 (1990) 541-552
12. Chen W.J., Dong C.F., Chiou L.Y., and Chuang W.L. Potential role of Armigeres subalbatus (Diptera: Culicidae) in the transmission of Japanese encephalitis virus in the absence of rice culture on Liu-chiu islet, Taiwan. J Med Entomol 37 (2000) 108-113
13. Chiou S.S., and Chen W.J. Mutations in the NS3 gene and 3′-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus. Virology 289 (2001) 129-136
14. Liu H., Chiou S.S., and Chen W.J. Differential binding efficiency between the envelope protein of Japanese encephalitis virus variants and heparan sulfate on the cell surface. J Med Virol 72 (2004) 618-624
15. Chiou S.S., Liu H., Chuang C.K., Lin C.C., and Chen W.J. Fitness of Japanese encephalitis virus to Neuro-2a cells is determined by interactions of the viral envelope protein with highly sulfated glycosaminoglycans on the cell surface. J Med Virol 76 (2005) 583-592
16. Novella I.S., Elena S.F., Moya A., Domingo E., and Holland J.J. Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J Virol 69 (1995) 2869-2872
17. Solomon T., Ni H., Beasley D.W., Ekkelenkamp M., Cardosa M.J., and Barrett A.D. Origin and evolution of Japanese encephalitis virus in Southeast Asia. J Virol 77 (2003) 3091-3098
18. Uchil P.D., and Satchidanandam V. Phylogenetic analysis of Japanese encephalitis virus: envelope gene-based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg 65 (2001) 242-251
19. Chen L.K., Lin Y.L., Liao C.L., Lin C.G., Huang Y.L., Yeh C.T., et al. Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology 223 (1996) 79-88
20. Lee E., and Lobigs M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol 74 (2000) 8867-8875
21. Ni H., and Barrett A.D. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. Virology 241 (1998) 30-36
22. Theiler M., Smith H.H., and Mortimer P. The use of yellow fever virus modified by in vitro cultivation for human immunization. Rev Med Virol 10 (2000) 3-16
23. Mandl C.W., Kroschewski H., Allison S.L., Kofler R., Holzmann H., Meixner T., et al. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol 75 (2001) 5627-5637
24. Lai C.J., and Monath T.P. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv Virus Res 61 (2003) 469-509
25. Liu J.J., Tsai T.H., Chang T.J., and Wong M.L. Cloning and sequencing of complete cDNA of Japanese encephalitis virus YL strain in Taiwan. Virus Genes 26 (2004) 193-198
26. Zhao Z., Date T., Li Y., Kato T., Miyamoto M., Yasui K., et al. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. J Gen Virol 86 (2005) 2209-2220
27. Kimura T., and Ohyama A. Association between the pH-dependent conformational change of West Nile flavivirus E protein and virus-mediated membrane fusion. J Gen Virol 69 (1988) 1247-1254
28. Stiasny K., and Heinz F.X. Flavivirus membrane fusion. J Gen Virol 87 (2006) 2755-2766
29. Monath T.P., Arroyo J., Levenbook I., Zhang Z.X., Catalan J., Draper K., et al. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol 76 (2002) 1932-1943
30. Guirakhoo F., Zhang Z., Myers G., Johnson B.W., Pugachev K., Nichols R., et al. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys. J Virol 78 (2004) 9998-10008
31. Arroyo J., Guirakhoo F., Fenner S., Zhang Z.X., Monath T.P., and Chambers T.J. Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 75 (2001) 934-942
32. Monath T.P., Myers G.A., Beck R.A., Knauber M., Scappaticci K., Pullano T., et al. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys. Biologicals 33 (2005) 131-144
33. Klimstra W.B., Ryman K.D., and Johnston R.E. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 72 (1998) 7357-7366
34. Lee E., Hall R.A., and Lobigs M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78 (2004) 8271-8280
35. Licon Luna R.M., Lee E., Mullbacher A., Blanden R.V., Langman R., and Lobigs M. Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice. J Virol 76 (2002) 3202-3211
36. Bernfield M., Kokenyesi R., Kato M., Hinkes M.T., Spring J., Gallo R.L., et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8 (1992) 365-393
37. Sa-Carvalho D., Rieder E., Baxt B., Rodarte R., Tanuri A., and Mason P.W. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 71 (1997) 5115-5123
38. Byrnes A.P., and Griffin D.E. Binding of Sindbis virus to cell-surface heparan sulfate. J Virol 72 (1998) 7349-7356
39. Bernard K.A., Klimstra W.B., and Johnson R.E. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276 (2000) 93-103
40. Sumiyoshi H., Tignor G.H., and Shope R.E. Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J Infect Dis 171 (1995) 1144-1151
41. Zhang S., Li L., Woodson S.E., Huang C.Y., Kinney R.M., Barrett A.D., et al. A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology 353 (2006) 35-40
42. Chiou S.S., Tsai K.H., Huang C.G., Liao Y.K., and Chen W.J. High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus. Vaccine 25 (2007) 1437-1443